Allogeneic Stem Cell Transplant Myeloma Trials

Allogeneic Transplant is a type of stem cell transplant that utilizes a donor (not from own) pre-collected stem cell to rescue the bone marrow from the toxic effect of a very high dose chemotherapy.

SparkCures ID	22
Generic Name	Allogeneic Stem Cell Transplant
Treatment Classifications	Allogeneic Stem Cell Transplant

All Clinical Trials

View all active clinical trials around the US.

Verified

Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant

View Trial

Verified

Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant

View Trial

Verified

Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis

View Trial

Verified

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

View Trial

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

View Trial

Verified

Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma

IPILIMUMAB

View Trial

Verified

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML

View Trial

Verified

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

View Trial

Verified

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Acute Leukemia After T Cell Depleted Allo-HSCT

View Trial

Verified

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

View Trial

Verified

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

View Trial

Verified

Allogeneic Hematopoietic Stem Cell Transplantation of αβ+ T Lymphocyte Depleted Grafts Conditioned with a Reduced Intensity Regimen in Patients with Hematolo...

View Trial

Verified

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...

View Trial

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...

View Trial

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

View Trial

Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...

View Trial

Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) for Hematolog...

View Trial

Umbilical Cord Blood (UCB) Transplant for Hematological Diseases Using a Non Myeloablative Prep

UMBILICAL CORD BLOOD TRANSPLANTATION

View Trial

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Pati...

View Trial

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients...

View Trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

View Trial

Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen for Hapl...

View Trial

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hemato...

View Trial

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transpl...

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

View Trial

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Ma...

View Trial

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...

View Trial

Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen for Hapl...

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

View Trial

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

View Trial

Verified

Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma

IPILIMUMAB

View Trial

Verified

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

View Trial

Verified

Allogeneic Hematopoietic Stem Cell Transplantation of αβ+ T Lymphocyte Depleted Grafts Conditioned with a Reduced Intensity Regimen in Patients with Hematolo...

View Trial

Verified

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...

View Trial

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...

View Trial

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

View Trial

Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...

View Trial

Umbilical Cord Blood (UCB) Transplant for Hematological Diseases Using a Non Myeloablative Prep

UMBILICAL CORD BLOOD TRANSPLANTATION

View Trial

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Pati...

View Trial

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients...

View Trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

View Trial

Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen for Hapl...

View Trial

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hemato...

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

View Trial

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

View Trial

Verified

Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma

IPILIMUMAB

View Trial

Verified

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...

View Trial

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...

View Trial

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

View Trial

Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...

View Trial

Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) for Hematolog...

View Trial

Umbilical Cord Blood (UCB) Transplant for Hematological Diseases Using a Non Myeloablative Prep

UMBILICAL CORD BLOOD TRANSPLANTATION

View Trial

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Pati...

View Trial

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients...

View Trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

View Trial

Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen for Hapl...

View Trial

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hemato...

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

View Trial

Smoldering Myeloma

No active clinical trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

No active clinical trials

Allogeneic Transplant and Precursor Myeloma Cells with William Matsui, MD, Johns Hopkins

February 16, 2018

Allogeneic (or donor) stem cell transplant has become much safer over the last 20 years. For those who have high risk myeloma features, it should be considered as a potential option. Dr. William Matsui, MD of Johns Hopkins University (and soon to be leading a myeloma practice in Austin, TX) shares his experience with allo transplant for all patients, regardless of their age.

Allogeneic Stem Cell Transplant

Overview

Clinical Trials

Resources